V118L (p.Val118Leu) variant of AGT (Angiotensinogen)

V118L (p.Val118Leu) in AGT (Angiotensinogen) is a missense change. Clinical records from EBI and UniProt describe it as uncertain significance. The available variant effect predictions contribute to a CATVariant prioritization score of 0.13 / 1. The record also includes population frequency data and structural context.

V118L (p.Val118Leu) variant details